Literature DB >> 17715210

Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor.

Francesco Angelucci1, Valerio Ricci, Massimiliano Pomponi, Gianluigi Conte, Aleksander A Mathé, Pietro Attilio Tonali, Pietro Bria.   

Abstract

Chronic cocaine and heroin users display a variety of central nervous system (CNS) dysfunctions including impaired attention, learning, memory, reaction time, cognitive flexibility, impulse control and selective processing. These findings suggest that these drugs may alter normal brain functions and possibly cause neurotoxicity. Neurotrophins are a class of proteins that serve as survival factors for CNS neurons. In particular, nerve growth factor (NGF) plays an important role in the survival and function of cholinergic neurons while brain-derived neurotrophic factor (BDNF) is involved in synaptic plasticity and in the maintenance of midbrain dopaminergic and cholinergic neurons. In the present study, we measured by enzyme-linked immunosorbent assay (ELISA) the NGF and BDNF levels in serum of three groups of subjects: heroin-dependent patients, cocaine-dependent patients and healthy volunteers. Our goal was to identify possible change in serum neurotrophins in heroin and cocaine users. BDNF was decreased in heroin users whereas NGF was decreased in both heroin and cocaine users. These findings indicate that NGF and BDNF may play a role in the neurotoxicity and addiction induced by these drugs. In view of the neurotrophin hypothesis of schizophrenia the data also suggest that reduced level of neurotrophins may increase the risk of developing psychosis in drug users.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17715210     DOI: 10.1177/0269881107078491

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  33 in total

Review 1.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 2.  Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.

Authors:  Wendy J Lynch; Alexis B Peterson; Victoria Sanchez; Jean Abel; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2013-06-24       Impact factor: 8.989

3.  Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress.

Authors:  Thiago W Viola; Saulo G Tractenberg; Mateus Luz Levandowski; Júlio Carlos Pezzi; Moisés Evandro Bauer; Antonio Lúcio Teixeira; Rodrigo Grassi-Oliveira
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

4.  Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats.

Authors:  Shiou-Lan Chen; Pao-Luh Tao; Chun-Hsien Chu; Shih-Heng Chen; Hsiang-En Wu; Leon F Tseng; Jau-Shyong Hong; Ru-Band Lu
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-29       Impact factor: 4.147

5.  Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study.

Authors:  Carrol D'Sa; Helen C Fox; Adam K Hong; Ralph J Dileone; Rajita Sinha
Journal:  Biol Psychiatry       Date:  2011-07-08       Impact factor: 13.382

6.  Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal.

Authors:  Anne Orgle Sordi; Flavio Pechansky; Felix Henrique Paim Kessler; Flávio Kapczinski; Bianca Pfaffenseller; Carolina Gubert; Bianca Wollenhaupt de Aguiar; Joana Correa de Magalhães Narvaez; Felipe Ornell; Lisia von Diemen
Journal:  Psychopharmacology (Berl)       Date:  2014-03-28       Impact factor: 4.530

7.  Brain-derived neurotrophic factor and addiction: Pathological versus therapeutic effects on drug seeking.

Authors:  Jacqueline M Barker; Jane R Taylor; Taco J De Vries; Jamie Peters
Journal:  Brain Res       Date:  2014-11-04       Impact factor: 3.252

8.  Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.

Authors:  Valerio Ricci; Giovanni Martinotti; Francesca Gelfo; Federico Tonioni; Carlo Caltagirone; Pietro Bria; Francesco Angelucci
Journal:  Psychopharmacology (Berl)       Date:  2010-12-14       Impact factor: 4.530

9.  HIV-1 decreases the levels of neurotrophins in human lymphocytes.

Authors:  Valeriya Avdoshina; Alfredo Garzino-Demo; Alessia Bachis; Maria C G Monaco; Pauline M Maki; Rochelle E Tractenberg; Chenglong Liu; Mary A Young; Italo Mocchetti
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

10.  Effect of chronic morphine on the dentate gyrus neurogenic microenvironment.

Authors:  A A Arguello; S J Fischer; J R Schonborn; R W Markus; R A Brekken; A J Eisch
Journal:  Neuroscience       Date:  2009-01-19       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.